Haapasalo et al. [20] demonstrated that Trx expression was associated with worse prognosis in diffuse astrocytomas (n = 391) and Trx was an independent prognostic factor in addition to histology and proliferation. The gene discussed is TXN; the disease is diffuse astrocytoma.